{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:56:35Z","timestamp":1787068595011,"version":"build-2736575974"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>Historically, the brain has been viewed as a specialized neurovascular inert organ with a distinctive immune privilege. Therefore, radiation-induced extracranial abscopal effects would be considered an unusual phenomenon due to the difficulty of the immunogenic signaling molecules to travel across the blood-brain barrier (BBB). However, it is now possible that localized central nervous system radiation has the ability to disrupt the structural integrity of the BBB and increase its endothelial permeability allowing the free passage of immunogenic responses between the intracranial and extracranial compartments. Thus, the nascent tumor\u2013associated antigens produced by localized brain radiation can travel across the BBB into the rest of the body to modulate the immune system and induce extracranial abscopal effects. In clinical practice, localized brain radiation therapy\u2013induced extracranial abscopal effects are a rarely seen phenomenon in metastatic melanoma and other advanced cancers. In this article, we provide a detailed overview of the current state of knowledge and clinical experience of central nervous system radiation\u2013induced extracranial abscopal effects in patients with malignant melanoma. Emerging data from a small number of case reports and cohort studies of various malignancies has significantly altered our earlier understanding of this process by revealing that the brain is neither isolated nor passive in its interactions with the body\u2019s immune system. In addition, these studies provide clinical evidence that the brain is capable of interacting actively with the extracranial peripheral immune system. Thus, localized radiation treatment to 1 or more locations of brain metastases can induce extracranial abscopal responses. Collectively, these findings clearly demonstrate that localized brain radiation therapy\u2013induced abscopal effects traverses the BBB and trigger tumor regression in the nonirradiated extracranial locations.<\/jats:p>","DOI":"10.1097\/coc.0000000000000760","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T16:05:56Z","timestamp":1602432356000},"page":"836-845","source":"Crossref","is-referenced-by-count":5,"title":["Brain Radiation Induced Extracranial Abscopal Effects in Metastatic Melanoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Mark A.","family":"D\u2019Andrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Kesava","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.suc.2019.09.010","article-title":"Role of radiation in the era of effective systemic therapy for melanoma","volume":"100","author":"Wernicke","year":"2020","journal-title":"Surg Clin North Am"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2019.08.015","article-title":"Current role of radiation therapy in the management of malignant central nervous system tumors","volume":"34","author":"Farooqi","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.21037\/tlcr.2019.05.01","article-title":"What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?","volume":"8","author":"Nesbit","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrclinonc.2012.194","article-title":"Image-guided radiotherapy: from current concept to future perspectives","volume":"9","author":"Jaffray","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00411-013-0497-2","article-title":"Current concepts in clinical radiation oncology","volume":"53","author":"Orth","year":"2014","journal-title":"Radiat Environ Biophys"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother Oncol"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrclinonc.2012.203","article-title":"Past, present, and future of radiotherapy for the benefit of patients","volume":"10","author":"Thariat","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3332\/ecancer.2017.785","article-title":"Recent advances in radiation oncology","volume":"11","author":"Garibaldi","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S1415-475738420150019","article-title":"Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer","volume":"38","author":"Borrego-Soto","year":"2015","journal-title":"Genet Mol Biol"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13277-010-0042-8","article-title":"Radiation-induced cell death mechanisms","volume":"31","author":"Eriksson","year":"2010","journal-title":"Tumour Biol"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.cdd.4402148","article-title":"Cell death modalities: classification and pathophysiological implications","volume":"14","author":"Galluzzi","year":"2007","journal-title":"Cell Death Differ"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/erc.0.0060041","article-title":"Induction of cell death by radiotherapy","volume":"6","author":"Ross","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/09553008914552491","article-title":"The 5Rs of radiobiology","volume":"56","author":"Steel","year":"1989","journal-title":"Int J Radiat Biol"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13566-019-00391-1","article-title":"The systemic immunostimulatory effects of radiation therapy producing overall tumor control through the abscopal effect","volume":"8","author":"D\u2019Andrea","year":"2019","journal-title":"J Radiat Oncol"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/COC.0000000000000651","article-title":"Systemic immunostimulatory effects of radiation therapy improves the outcomes of patients with advanced NSCLC receiving immunotherapy","volume":"43","author":"D\u2019Andrea","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation; radiobiology or medicine?","volume":"26","author":"Mole","year":"1953","journal-title":"Br J Radiol"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijrobp.2018.01.094","article-title":"Abscopal effects with hypofractionated schedules extending into the effector phase of the tumor-specific T-cell response","volume":"101","author":"Zhang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20230903","first-page":"6028","article-title":"Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer","volume":"59","author":"Chakravarty","year":"1999","journal-title":"Cancer Res"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3109\/09553000903242099","article-title":"Radiation induces an antitumour immune response to mouse melanoma","volume":"85","author":"Perez","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest"},{"key":"R25-20230903","doi-asserted-by":"crossref","first-page":"e92572","DOI":"10.1371\/journal.pone.0092572","article-title":"Radiotherapy-induced anti-tumor immunity contributes to the therapeutic efficacy of irradiation and can be augmented by CTLA-4 blockade in a mouse model","volume":"9","author":"Yoshimoto","year":"2014","journal-title":"PLoS One"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-12-0210","article-title":"Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies","volume":"72","author":"Verbrugge","year":"2012","journal-title":"Cancer Res"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1158\/0008-5472.CAN-04-1525","article-title":"Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes","volume":"64","author":"Garnett","year":"2004","journal-title":"Cancer Res"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-09-2982","article-title":"Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy","volume":"70","author":"Takeshima","year":"2010","journal-title":"Cancer Res"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/COC.0000000000000623","article-title":"Extracranial abscopal effects induced by brain radiation in advanced lung cancer","volume":"42","author":"D\u2019Andrea","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fonc.2014.00325","article-title":"Combinations of immunotherapy and radiation in cancer therapy","volume":"4","author":"Vatner","year":"2014","journal-title":"Front Oncol"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imr.12573","article-title":"Abscopal, immunological effects of radiotherapy: narrowing the gap between clinical and preclinical experiences","volume":"280","author":"Brix","year":"2017","journal-title":"Immunol Rev"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1039\/b911313b","article-title":"Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?","volume":"5","author":"Kamrava","year":"2009","journal-title":"Mol Biosyst"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"R35-20230903","first-page":"1064","article-title":"Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges","volume":"22","author":"Hodge","year":"2008","journal-title":"Oncology (Williston Park)"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/CMR.0000000000000382","article-title":"Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis","volume":"27","author":"Gardner","year":"2017","journal-title":"Melanoma Res"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ctrv.2016.03.003","article-title":"Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: a systematic review","volume":"45","author":"Spagnolo","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"R39-20230903","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.25634","article-title":"Prognostic factors for survival in melanoma patients with brain metastases","volume":"117","author":"Davies","year":"2011","journal-title":"Cancer"},{"key":"R41-20230903","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","article-title":"Determinants of outcome in melanoma patients with cerebral metastases","volume":"22","author":"Fife","year":"2004","journal-title":"J Clin Oncol"},{"key":"R42-20230903","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ejca.2011.06.052","article-title":"New drugs in melanoma: it\u2019s a whole new world","volume":"47","author":"Eggermont","year":"2011","journal-title":"Eur J Cancer"},{"key":"R43-20230903","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1158\/1078-0432.CCR-16-0714","article-title":"FDA approval of nivolumab for the first-line treatment of patients with BRAF(V600) wild-type unresectable or metastatic melanoma","volume":"23","author":"Beaver","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R44-20230903","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1158\/1078-0432.CCR-16-0712","article-title":"US FDA Approval summary: nivolumab for treatment of unresectable or metastatic melanoma following progression on ipilimumab","volume":"23","author":"Hazarika","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R45-20230903","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1158\/1078-0432.CCR-16-0664","article-title":"FDA approval summary: pembrolizumab for the treatment of patients with unresectable or metastatic melanoma","volume":"23","author":"Barone","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R46-20230903","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1158\/1078-0432.CCR-16-0663","article-title":"FDA approval summary: accelerated approval of pembrolizumab for second-line treatment of metastatic melanoma","volume":"23","author":"Chuk","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R47-20230903","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol"},{"key":"R48-20230903","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-065X.2006.00441.x","article-title":"CNS immune privilege: hiding in plain sight","volume":"213","author":"Carson","year":"2006","journal-title":"Immunol Rev"},{"key":"R49-20230903","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","article-title":"Immunologic privilege in the central nervous system and the blood-brain barrier","volume":"33","author":"Muldoon","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"R50-20230903","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/08830185.2017.1357719","article-title":"CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ","volume":"37","author":"Negi","year":"2018","journal-title":"Int Rev Immunol"},{"key":"R51-20230903","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.clgc.2012.01.004","article-title":"Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell carcinoma: abscopal effect prevented by the blood-brain barrier?","volume":"10","author":"Ishiyama","year":"2012","journal-title":"Clin Genitourin Cancer"},{"key":"R52-20230903","first-page":"25","article-title":"Breaking ignorance: the case of the brain","volume":"305","author":"Wekerle","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"R53-20230903","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/NMM:7:3:217","article-title":"Failed central nervous system regeneration: a downside of immune privilege?","volume":"7","author":"Bechmann","year":"2005","journal-title":"Neuromolecular Med"},{"key":"R54-20230903","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri1130","article-title":"Three or more routes for leukocyte migration into the central nervous system","volume":"3","author":"Ransohoff","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R55-20230903","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2013.04.005","article-title":"Innate immunity in the CNS: redefining the relationship between the CNS and its environment","volume":"78","author":"Lampron","year":"2013","journal-title":"Neuron"},{"key":"R56-20230903","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-018-1304-4","article-title":"Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice","volume":"15","author":"Unger","year":"2018","journal-title":"J Neuroinflammation"},{"key":"R57-20230903","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","article-title":"Neuroinflammation as a common feature of neurodegenerative disorders","volume":"10","author":"Guzman-Martinez","year":"2019","journal-title":"Front Pharmacol"},{"key":"R58-20230903","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"key":"R59-20230903","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.01.002","article-title":"Anatomy and physiology of the blood-brain barrier","volume":"38","author":"Serlin","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"R60-20230903","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R61-20230903","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"R62-20230903","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/138161208784705432","article-title":"The blood-central nervous system barriers actively control immune cell entry into the central nervous system","volume":"14","author":"Engelhardt","year":"2008","journal-title":"Curr Pharm Des"},{"key":"R63-20230903","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.0802258","article-title":"IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis","volume":"183","author":"McCandless","year":"2009","journal-title":"J Immunol"},{"key":"R64-20230903","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"R65-20230903","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"key":"R66-20230903","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0014-4886(90)90017-M","article-title":"The blood-brain barrier protects foreign antigens in the brain from immune attack","volume":"108","author":"Pollack","year":"1990","journal-title":"Exp Neurol"},{"key":"R67-20230903","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/19420862.2017.1409320","article-title":"Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system","volume":"10","author":"Thom","year":"2018","journal-title":"Mabs"},{"key":"R68-20230903","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2011.11.022","article-title":"Radiation-induced blood-brain barrier damages: an in vitro study","volume":"1433","author":"Fauquette","year":"2012","journal-title":"Brain Res"},{"key":"R69-20230903","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0360-3016(90)90376-U","article-title":"Effects of ionizing radiation on the blood brain barrier permeability to pharmacologically active substances","volume":"19","author":"Trnovec","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R70-20230903","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/neuonc\/now137","article-title":"Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery","volume":"18","author":"Appelboom","year":"2016","journal-title":"Neuro Oncol"},{"key":"R71-20230903","first-page":"2694","article-title":"Apoptosis in the subependyma of young adult rats after single and fractionated doses of x-rays","volume":"57","author":"Shinohara","year":"1997","journal-title":"Cancer Res"},{"key":"R72-20230903","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3940(96)12572-6","article-title":"Apoptosis is induced in the subependyma of young adult rats by ionizing irradiation","volume":"208","author":"Bellinzona","year":"1996","journal-title":"Neurosci Lett"},{"key":"R73-20230903","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/0360-3016(90)90364-P","article-title":"Influence of radiation on the blood-brain barrier and optimum time of chemotherapy","volume":"19","author":"Qin","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R74-20230903","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00000421-199706000-00011","article-title":"Effect of brain irradiation on blood-CSF barrier permeability of chemotherapeutic agents","volume":"20","author":"Qin","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"R75-20230903","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3857\/roj.2019.00437","article-title":"Extracranial systemic antitumor response through the abscopal effect induced by brain radiation in a patient with metastatic melanoma","volume":"37","author":"D\u2019Andrea","year":"2019","journal-title":"Radiat Oncol J"},{"key":"R76-20230903","first-page":"e2034","article-title":"Advanced survival in patients with multiple irradiations for brain melanoma metastases and associated abscopal effect","volume":"10","author":"Galkin","year":"2018","journal-title":"Cureus"},{"key":"R77-20230903","first-page":"e1947","article-title":"Case report of extended survival and quality of life in a melanoma patient with multiple brain metastases and review of literature","volume":"9","author":"Sperduto","year":"2017","journal-title":"Cureus"},{"key":"R78-20230903","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/COC.0b013e3182940dc3","article-title":"Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma","volume":"38","author":"Okwan-Duodu","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"R79-20230903","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00105-014-3567-8","article-title":"Abscopal effect in the treatment of malignant melanoma","volume":"66","author":"Thallinger","year":"2015","journal-title":"Hautarzt"},{"key":"R80-20230903","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijrobp.2015.01.004","article-title":"Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment","volume":"92","author":"Kiess","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R81-20230903","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bjd.12136","article-title":"Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis","volume":"168","author":"Teulings","year":"2013","journal-title":"Br J Dermatol"},{"key":"R82-20230903","first-page":"946392","article-title":"A patient with HIV treated with ipilimumab and stereotactic radiosurgery for melanoma metastases to the brain","volume":"2013","author":"Ruzevick","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"R83-20230903","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJMcpc1302332","article-title":"Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma","volume":"369","author":"Sullivan","year":"2013","journal-title":"N Engl J Med"},{"key":"R84-20230903","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1158\/2326-6066.CIR-15-0156","article-title":"Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma","volume":"4","author":"Theurich","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"R85-20230903","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40425-015-0095-8","article-title":"Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review","volume":"3","author":"Schoenfeld","year":"2015","journal-title":"J Immunother Cancer"},{"key":"R86-20230903","doi-asserted-by":"crossref","first-page":"e28780","DOI":"10.4161\/onci.28780","article-title":"Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy","volume":"3","author":"Grimaldi","year":"2014","journal-title":"Oncoimmunology"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:09:06Z","timestamp":1693699746000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000760","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}